Fulgent Genetics Completes Acquisition of Bako Diagnostics and StrataDx Fulgent Genetics (NASDAQ: FLGT) completed the acquisition of Bako Diagnostics and StrataDx on March 17, 2026. The company acquired certain assets of Bako and purchased StrataDx for a combined cash purchase price of approximately $56.9 million, subject to post-closing adjustments.The acquisitions add a premier pathology laboratory and a premier dermatopathology laboratory to Fulgent's laboratory services businesses. Financial and legal advisors to both sides were disclosed.

#FLGT Fulgent Genetics Completes Acquisition of Bako Diagnostics and StrataDx

www.stocktitan.net/news/FLGT/fulgent-geneti...

Original post on benzinga.com

Dow Dips Over 600 Points; US Producer Prices Increase In January US stocks traded lower, Dow down 600 points. Nasdaq and S&P also fell. Consumer staples up, tech down. Producer prices rose in J...

#AAOI #EBS #ENSC #Equities #FLGT #Mid-Morning #Market #Update […]

[Original post on benzinga.com]

Fulgent Reports Fourth Quarter and Full Year 2025 Financial Results Fulgent Genetics (NASDAQ: FLGT) reported Q4 2025 revenue of $83.3M (+9% YoY) and FY 2025 revenue of $322.7M (+14% YoY). GAAP loss for FY was $60.5M (loss of $1.97/share); non-GAAP income was $13.2M ($0.42/share). Cash and equivalents totaled $705.5M excluding an expected ~$106.3M tax refund. Management flagged a large customer moving volume in-house and provided 2026 guidance: revenue ~$350M, non-GAAP loss ~$(1.45) per share, and pro forma cash ~$685M, assuming a ~$56M acquisition spend for Bako and Strata Dx.

#FLGT Fulgent Reports Fourth Quarter and Full Year 2025 Financial Results

www.stocktitan.net/news/FLGT/fulgent-report...

Leading Indicators, Monday January 5, 2026 – Crystal Equity Research

Small-cap stocks in new downtrend according to average directional index, Mon Jan 5th - #INFU #LUCY #TOUR #ORKA #FLGT #DGNX #AVBP #TK #LB #CXM #CATO #AMPY - More: crystalequityresearch.com/leading-indi... - #smallcap

Fulgent Genetics Agrees to Acquire Bako Diagnostics and StrataDx Fulgent Genetics, Inc., a technology-based company with a well-established laboratory services business and a therapeutic development business, today announced that it has entered into a definitive agreement to acquire selected assets of Bako Diagnostics, a premier pathology laboratory headquartered in Alpharetta, GA and to acquire StrataDx, a premier...

#FLGT Fulgent Genetics Agrees to Acquire Bako Diagnostics and StrataDx

www.stocktitan.net/news/FLGT/fulgent-geneti...

Fulgent Reports Third Quarter 2025 Financial Results Fulgent Genetics, Inc., a technology-based company with a well-established laboratory services business and a therapeutic development business, today announced financial results for its third quarter ended September 30, 2025.. Revenue of $84.1 million, growing 17% year-over-year GAAP loss of $6.6 million, or per share Non-GAAP income of $4.5 million, or...

#FLGT Fulgent Reports Third Quarter 2025 Financial Results

www.stocktitan.net/news/FLGT/fulgent-report...

Fulgent Shares Preliminary Data from Poster Presentation at ESMO 2025 Conference Fulgent Genetics, Inc., a technology-based company with a well-established clinical diagnostic business and a therapeutic development business, today announced preliminary clinical data as of September 25, 2025, the preliminary data cutoff from its ongoing phase 2 clinical trial investigating FID-007 in combination with cetuximab in≤ 2 nd line...

#FLGT Fulgent Shares Preliminary Data from Poster Presentation at ESMO 2025 Conference

www.stocktitan.net/news/FLGT/fulgent-shares...

Fulgent (FLGT) Q2 Revenue Jumps 16% | The Motley Fool

#FLGT #5ab68c2e-17b6-47fe-b482-2665b87d477c #data-news

Origin | Interest | Match

Fulgent Genetics Beats Q2 Expectations: Core Revenue Jumps 16% as Company Raises Full-Year Outlook Discover Fulgent's Q2 performance: Core revenue hits $81.7M, guidance raised to $320M. Strong cash position of $777.5M signals growth potential. See full results.

#FLGT Fulgent Reports Second Quarter 2025 Financial Results

www.stocktitan.net/news/FLGT/fulgent-report...

Breakthrough: Fulgent Genetics Leads Europe's Genetic Testing Market with Landmark CE Mark Approval First laboratory to receive EU certification for comprehensive 4600-gene diagnostic testing system. European expansion unlocks major market opportunity. Learn more.

#FLGT Fulgent Genetics Receives EU CE Mark for FulgentExome & FulgentPLM

www.stocktitan.net/news/FLGT/fulgent-geneti...

Investigation Launched by Pomerantz Law Firm for Fulgent Genetics Investors Amid Securities Fraud Concerns Pomerantz Law Firm is investigating potential securities fraud claims against Fulgent Genetics, Inc. Investors may inquire for participation in a class action lawsuit.

Investigation Launched by Pomerantz Law Firm for Fulgent Genetics Investors Amid Securities Fraud Concerns #United_States #New_York #Pomerantz_Law #Fulgent_Genetics #FLGT

Investor Alert: Pomerantz Law Firm Investigates Claims for Fulgent Genetics Investors Amid Concerns Pomerantz LLP is investigating allegations of securities fraud involving Fulgent Genetics, Inc., following a disclosure by the company that raised investor concerns.

Investor Alert: Pomerantz Law Firm Investigates Claims for Fulgent Genetics Investors Amid Concerns #USA #New_York #Pomerantz_LLP #Fulgent_Genetics #FLGT

Pomerantz Law Firm Launches Investigation Into Fulgent Genetics, Inc. Amid Potential Securities Fraud Claims Pomerantz LLP is looking into possible securities fraud involving Fulgent Genetics, Inc., impacting its investors following recent legal disclosures.

Pomerantz Law Firm Launches Investigation Into Fulgent Genetics, Inc. Amid Potential Securities Fraud Claims #United_States #New_York #Pomerantz_LLP #Fulgent_Genetics #FLGT

Pomerantz Law Firm Probes Potential Securities Violations at Fulgent Genetics, Inc. Pomerantz LLP is investigating claims regarding possible securities fraud involving Fulgent Genetics, Inc. This could affect investors significantly.

Pomerantz Law Firm Probes Potential Securities Violations at Fulgent Genetics, Inc. #United_States #New_York #Pomerantz_LLP #Fulgent_Genetics #FLGT

Investigating Investor Claims against Fulgent Genetics: A Legal Perspective Pomerantz Law Firm is probing potential fraud claims involving Fulgent Genetics, following their recent disclosure of a DOJ investigation.

Investigating Investor Claims against Fulgent Genetics: A Legal Perspective #USA #New_York #Pomerantz_LLC #Fulgent_Genetics #FLGT

Fulgent Reports First Quarter 2025 Financial Results Fulgent Genetics (NASDAQ: FLGT) reported its Q1 2025 financial results, showing core revenue growth of 16% year-over-year to $73.5 million. The company posted a GAAP loss of $11.5 million (($0.37) per share) but achieved non-GAAP income of $1.2 million ($0.04 per share). Fulgent maintained a strong cash position of $814.6 million ($26.60 per share) and continued its share repurchase program, buying back 516,000 shares for $8.7 million. For full-year 2025, Fulgent reiterated its guidance, expecting core revenue of approximately $310 million, with projected GAAP loss of ($1.95) per share and non-GAAP loss of ($0.65) per share. The company anticipates ending 2025 with approximately $770 million in cash and investments.

#FLGT Fulgent Reports First Quarter 2025 Financial Results

www.stocktitan.net/news/FLGT/fulgent-report...

💼 INSIDER BUY: $FLGT
Opinion: "This name interests me tremendously," but the stock has already jumped 16% from his purchase price. We're watching closely for potential entry opportunities in this company.
Read more: buff.ly/18scvP7
#InsiderBuying #TheInsidersFund #FLGT #Genetics #DiagnosticTesting

💼 INSIDER BUY: $FLGT
Opinion: "This name interests me tremendously," but the stock has already jumped 16% from his purchase price. We're watching closely for potential entry opportunities in this company.
Read more: buff.ly/18scvP7
#InsiderBuying #TheInsidersFund #FLGT #Genetics #DiagnosticTesting

logos for Masterbrand, Diamondback Energy, FTAI Aviation, Kratos, Fulgent, Huntsman, and Modine. Plus the Insiders Fund logo, and website: www.theinsidersfund.com

logos for Ziff Davis, Walker Dunlop, Grocery Outlet, TriMas, Dentsply Sirona, Treace, Moderna, and The Insiders Fund logo and website: www.theinsidersfund.com

Logos for Taboola, SolarEdge, Old Dominion Freight Line, Murphy Oil Corporation, Strategic Education, Inc, Parsons, and The Insiders Fund logo and website: www.theinsidersfund.com

🚨 Insider buys for this past week 🚨 Stay tuned. Will be opine over the buys this Sunday on my blog.🔎 📊 Stay tuned. #AMRC #BHVN #CABO #CCO #XRAY #KTOS #FANG #FTAI #FLGT #GO #HUN #MBC #MRNA #MOD #MUR #ODFL #PSN #CRM #STRA #SEDG #TBLA #TMCI #TRS #WD #ZD #InsiderBuying #StockMarket #TheInsidersFund

Can Fulgent's $828M Cash Reserves Fuel Growth Despite Ongoing Losses? Fulgent posts $283.5M annual revenue with 14% Q4 core growth, maintains $828.6M cash position, and projects $310M revenue for 2025 despite continued losses.

#FLGT Fulgent Reports Fourth Quarter and Full Year 2024 Financial Results

www.stocktitan.net/news/FLGT/fulgent-report...

Fulgent Genetics Earnings Alert: Q4 Results and 2024 Performance Coming February 28 - Key Details Inside Fulgent Genetics will report Q4 and full year 2024 financial results pre-market on February 28, followed by an investor conference call at 8:30 AM ET to discuss performance.

#FLGT Fulgent to Announce Fourth Quarter and Full Year 2024 Financial Results on Friday, February 28, 2025

www.stocktitan.net/news/FLGT/fulgent-to-ann...

NEWS: ( NASDAQ: #FLGT ) Fulgent Reports Second Quarter 2024 Financial Results

#StockMarket #News